-
FRISQ’s Interim Report Q3, 2021
CEO StatementDuring the quarter, we have reached a milestone in the collaboration with Capio Elderly and Mobile Care. The five-year agreement is being implemented across Capio’s clinics and start-up meetings have successfully been held with employees from Capio Geriatrics. FRISQ Care has been positively received and the software is said to make it easy to …
More -
FRISQ’s Interim Report Q2, 2021
CEO StatementFRISQ’s Capital Markets Day in May was a great opportunity to present where we are and where we are moving to. We could then, and can now, report that higher recurring revenues have had a positive effect on cash flow, along with a cost control that has shifted funds from administration to development and …
More -
Interim Report Q1, 2021 – Turnover exceeding previous full year
CEO Statement The pandemic continues to affect our industry in many ways. But although the room for long-term digitalisation decisions is small right now, FRISQ’s pilot projects continue to run as planned or better. Our clients’ innovation continue to depend heavily on FRISQ Care and we have in several instances been asked to increase our …
More -
FRISQ’s Annual Report for 2020 is published
The FRISQ Annual Report for 2020 is now available in Swedish on the www.frisqholding.se web site. The annual report may also on request be obtained by post; Please contact FRISQ at +46 8 120 131 21 alternatively email investor@frisq.se. The publication is a translation of the original Swedish text. In the event of inconsistency or discrepancy between the Swedish version and this publication, the Swedish language version shall prevail. For further information: George Thaw, CEO, FRISQinvestor@frisq.se …
More -
Report Q4 and Full Year 2020
January-December 2020 CEO Statement For us who work in the healthcare sector, the fourth quarter of 2020 was characterized as much by the global pandemic as previous quarters; In fact, almost more so since we have unfortunately been hit by a second corona wave before commencing large-scale vaccinations. It is a worrying situation for the …
More -
Interim Report Q3, 2020
CEO StatementAs we’re closing a busy quarter for FRISQ I’m proud to say we’ve carried out a fully subscribed, directed share issue of 78.75 million SEK. This capital infusion will strengthen our sales and implementation efforts in 2021. While we work hard to develop a product that drives both better health outcomes and patient engagement, …
More